Titan Medical shares rise as strategic review begins
** U.S.-listed shares of Titan Medical TMDI.O up ~17% at
45 cents
** Medical device maker says its board is considering a
strategic review of the company, including a corporate sale or
merger
** Adds that it has engaged Raymond James as financial
advisor
** Co says has not set a timeline for completion of the
strategic review process
** Including session moves, TMDI down ~26% YTD
(Reporting by Bhanvi Satija in Bengaluru)
((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))
Recent news on Conavi Medical
See all newsBrief: Conavi Medical Announces Pricing Of Public Offering Of Common Shares
Brief: Conavi Medical Announces Agreement With The Province Of Ontario As Part Of The Life Sciences Scale-Up Fund
Brief: Conavi Medical Submits Next Generation Novasight Hybrid Intravascular Imaging System To Us FDA For 510(K) Clearance
Brief: Conavi Medical Corp. Announces Closing Of $20M Public Offering
Brief: Titan Medical Says To Delist From Tsx & Apply To Re-List On TSX Venture Exchange